EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adaptive Bayesian Clinical Trials: The Past, Present, and Future of Clinical Research

Donald A Berry iD

Journal of Clinical Medicine · 25.07.2025 · 14 (15) · 5267

DOI: 10.3390/jcm14155267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 25.07.2025. Verfasst von Donald A Berry. Beteiligte Einrichtung: Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Decision-analytic Bayesian approaches are ideally suited for designing clinical trials. They have been used increasingly over the last 30 years in developing medical devices and drugs. A prototype trial is a bandit problem in which treating participants is as important as treating patients in clinical practice after the trial.

Methods

This article chronicles the use of the Bayesian approach in clinical trials motivated by bandit problems. It provides a comprehensive historical and practical review of Bayesian adaptive trials, with a focus on bandit-inspired designs.

Results

The 20th century saw advances in Bayesian methodology involving computer simulation. In the 21st century, methods motivated by bandit problems have been applied in designing scores of actual clinical trials. Fifteen such trials are described. By far the most important Bayesian contributions in clinical trials are the abilities to observe the accumulating results and to modify the future course of the trial on the basis of these observations. In the spirit of artificial intelligence, algorithms are programmed to learn the optimal treatment assignments over the remainder of the trial.

Conclusions

Bayesian trials are still nascent and represent a small minority of clinical trials, but their existence is changing the way investigators, regulators, and government and industry sponsors view innovation in clinical trials.

Schlagwörter

Stichwörter der Autor:innen

Bayesian predictive probabilitiesartificial intelligencebandit problemscomplex innovative designscontinually monitoring clinical trialsinterim analysespredicting clinical trial outcomessimulating clinical trials

Autor:innen und Institutionen

  • Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
  • Berry Consultants, LLC, Austin, TX 78746, USA.

ORCID-Profile: Donald A Berry

Zitieren

APA

Berry, D. A. (2025). Adaptive Bayesian Clinical Trials: The Past, Present, and Future of Clinical Research. Journal of Clinical Medicine, 14(15), 5267. https://doi.org/10.3390/jcm14155267

Vancouver

Berry DA. Adaptive Bayesian Clinical Trials: The Past, Present, and Future of Clinical Research. Journal of Clinical Medicine. 2025;14(15):5267. doi:10.3390/jcm14155267

BibTeX
@article{Berry2025,
  author = {Berry, Donald A},
  title = {Adaptive Bayesian Clinical Trials: The Past, Present, and Future of Clinical Research},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {15},
  pages = {5267},
  doi = {10.3390/jcm14155267}
}
Kostenlos starten →